Skip to main content
Galenica AG logo

Galenica AG — Investor Relations & Filings

Ticker · GALE ISIN · CH0360674466 LEI · 506700W4772BD8016Z20 SW Wholesale and retail trade
Open in API
Filings indexed 117 across all filing types
Latest filing 2026-05-28 Earnings Release
Country CH Switzerland
Listing SW GALE

About Galenica AG

https://www.galenica.com/en/index.php

Galenica AG is an integrated healthcare provider that operates a comprehensive network of companies. The group's core activities encompass pharmaceutical logistics and distribution, alongside the management of an extensive network of over 500 owned, joint venture, and partner pharmacies. Through its more than 20 business units, the company aims to deliver seamless, efficient, and personalized services to patients and customers. Galenica also develops digital healthcare solutions and offers a range of other healthcare services and products, positioning itself as a key partner in the healthcare market.

Recent filings

Filing Released Lang Actions
Galenica posts strong sales growth in a challenging market environment
Earnings Release Classification · 85% confidence The document is an ad hoc press release disclosing first four-month sales growth and outlook confirmation. It provides key highlights of periodic financial performance (revenue trends, segment breakdowns, guidance) without full financial statements. This matches an Earnings Release (initial announcement of periodical results). Q1 2026
2026-05-28 English
Forte croissance du chiffre d’affaires de Galenica dans un environnement de marché exigeant
Earnings Release Classification · 87% confidence The document is a press release (“Communiqué de presse”) issued under SIX ad hoc disclosure rules (“Annonce événementielle au sens de l’art. 53 RC”), presenting key financial performance metrics for the first four months of 2026, including revenue growth by segment and updated guidance. It provides headline results only, without full financial statements, fitting the definition of an initial periodical financial results announcement. Therefore, this is an Earnings Release. Q1 2026
2026-05-28 French
Galenica posts strong sales growth in a challenging market environment
Regulatory Filings Classification · 91% confidence The document is an ad hoc press release under Art. 53 LR providing a sales update for the first four months of the year. It does not contain full financial statements or management commentary typical of an interim report (IR) nor detailed P&L figures or net income disclosures typical of an earnings release (ER). Instead, it is a regulatory-required announcement of inside information under exchange rules. Therefore it falls under general regulatory announcements as a Regulatory Filing (RNS).
2026-05-28 English
Galenica mit starkem Umsatzwachstum in anspruchsvollem Marktumfeld
Earnings Release Classification · 90% confidence The document is an ad-hoc press release under Art. 53 KR that provides key revenue highlights for the first four months of 2026 (e.g., 7.3% growth, segment breakdowns, guidance confirmation). It is not a full interim report with detailed financial statements, but rather an initial announcement of periodical results and guidance. This matches the definition of an Earnings Release (ER). Q1 2026
2026-05-28 German
Healthcare players seek to establish the Electronic Prescription Switzerland service nationwide
Regulatory Filings Classification · 55% confidence The document is a corporate press release (media release) about a healthcare industry initiative to introduce an electronic prescription service in Switzerland. It does not present financial results or statutory reports (e.g., 10-K, IR, ER), nor does it announce board changes, dividends, share issues, M&A, or other specific transaction types. It is a general announcement, so it falls into the fallback category “Regulatory Filings (RNS).”
2026-04-27 English
Les acteurs du domaine de la santé veulent établir l’«E-Ordonnance Suisse» à l’échelle nationale
Regulatory Filings Classification · 20% confidence The document is a corporate press release via EQS News announcing a partnership initiative to roll out a digital e-prescription solution in Switzerland. It does not present financial results, regulatory filings, or detailed report content, and does not fit any specialized category (e.g., earnings release, annual report, M&A, governance, etc.). There is no dedicated “press release” category in the taxonomy, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-27 French

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.